New light scan could tell doctors if chemo is working in days
NCT ID NCT02510456
Summary
This study tested a new, non-invasive imaging tool called DOSI that uses harmless near-infrared light to scan breast tumors. The goal was to see if this scan, performed during the first days of chemotherapy, could predict whether the treatment would ultimately be successful. Researchers enrolled 24 women with breast cancer to compare the scan results with the final surgical pathology results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
Conditions
Explore the condition pages connected to this study.